GlassScriptPhysician profile
Jon J Morton
NPI 1174526198
$10,817.11
in general payments reported to CMS, 2019-2025
45 companies · $1,153 in 2025
The $1,153 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,390 · 2020: $852 · 2021: $1,499 · 2022: $1,098 · 2023: $1,897 · 2024: $1,927 · 2025: $1,153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,650 · Travel and Lodging: $1,327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,650.38 |
| Travel and Lodging | $1,327.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,712.80 | 2019 | |
| Intuitive Surgical, INC. | $1,433.06 | 2019-2024 | Da Vinci Surgical System |
| Procept Biorobotics Corporation | $1,342.02 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Boston Scientific Corporation | $993.16 | 2019-2025 | Ams 700, Lithovue |
| Janssen Biotech, INC. | $598.26 | 2019-2025 | Carvykti, Rybrevant, Erleada |
| Astellas Pharma US INC | $587.56 | 2019-2024 | Xtandi, Myrbetriq |
| Teleflex LLC | $526.16 | 2021-2023 | Urolift |
| Telix Pharmaceuticals | $477.50 | 2024 | |
| Abbvie INC. | $276.03 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $226.49 | 2019-2023 | Provenge |
| Calyxo, INC. | $204.15 | 2025 | Cvac Aspiration System |
| Tolmar Pharmaceuticals, INC. | $186.33 | 2021-2022 | |
| Palette Life Sciences, INC. | $183.20 | 2021 | |
| Myovant Sciences INC. | $180.44 | 2021-2022 | |
| Axonics, INC. | $167.58 | 2020-2022 |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Morton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.